Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Melatonin agonists from Takeda

Feb. 26, 1997

5-HT2C antagonists from Roche

Feb. 26, 1997

MS&D discloses tachykinin antagonists

Feb. 26, 1997

Watson's analgesic receives FDA approval

Feb. 25, 1997

Novo Nordisk prepares compounds with high affinity for 5-HT2C receptors

Feb. 25, 1997

Acorda and Elan to collaborate on spinal cord injury treatment

Feb. 24, 1997

Licenses offered for vasospasm therapy

Feb. 24, 1997

NIH seeks licensees for antispasmodic immunotoxin

Feb. 24, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...